CAS: 2169919-21-3
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | SNDX-5613 REF: TM-T12943CAS: 2169919-21-3 | 99.12% | 72,00 €~1.049,00 € | Mié 04 Dic 24 |
 | SNDX-5613 REF: 3D-ULD91921CAS: 2169919-21-3 | Min. 95% | A consultar | Mié 15 Ene 25 |
SNDX-5613
CAS:2169919-21-3
Revumenib (SNDX-5613) is a potent and selective oral inhibitor of menin-KMT2A interaction.Cost-effective and quality-assured.
Fórmula:
C32H47FN6O4S
Pureza:
99.12%
Forma y color:
Solid
Peso molecular:
630.82
Ref: TM-T12943
| 1mg | 72,00 € | ||
| 2mg | 95,00 € | ||
| 5mg | 157,00 € | ||
| 10mg | 269,00 € | ||
| 25mg | 531,00 € | ||
| 50mg | 761,00 € | ||
| 100mg | 1.049,00 € | ||
| 1mL*10mM (DMSO) | 217,00 € |
Entrega estimada en Estados Unidos, el Miércoles 4 de Diciembre de 2024
SNDX-5613
CAS:2169919-21-3
Revumenib, also known as SNDX-5613, is a potent and selective inhibitor of the interaction between …
Fórmula:
C32H47FN6O4S
Pureza:
Min. 95%
Peso molecular:
630.8 g/mol
Ref: 3D-ULD91921
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Miércoles 15 de Enero de 2025
